David Staskin, MD, Urology, Boston, MA, St. Elizabeth's Medical Center

DavidR.StaskinMD

Urology Boston, MA

Female Urology/Pelvic Medicine & Reconstructive Surgery

Associate Professor, Urology, Tufts University School of Medicine

Dr. Staskin is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Staskin's full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health SystemResidency, Urology, 1980 - 1984
  • University of California San DiegoInternship, Transitional Year, 1979 - 1980
  • Drexel University College of MedicineClass of 1979

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2010
  • MA State Medical License
    MA State Medical License 1985 - 2023
  • CA State Medical License
    CA State Medical License 1984 - Present
  • PA State Medical License
    PA State Medical License 1980 - 1988
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Boston Magazine Castle Connolly, 2013
  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
  • Top Doctors: New York Metro Area Castle Connolly, 2005-2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Urovant Sciences to Report First Fiscal Quarter 2020 Financial Results
    Urovant Sciences to Report First Fiscal Quarter 2020 Financial ResultsAugust 6th, 2020
  • Vibegron Demonstrates 1-Year Efficacy, Safety for Overactive Bladder
    Vibegron Demonstrates 1-Year Efficacy, Safety for Overactive BladderMay 16th, 2020
  • Urovant Sciences Presents Positive Clinical Efficacy & Safety Data on Lead Drug Candidate Vibegron at Virtual American Urological Association Annual Meeting
    Urovant Sciences Presents Positive Clinical Efficacy & Safety Data on Lead Drug Candidate Vibegron at Virtual American Urological Association Annual MeetingMay 14th, 2020
  • Join now to see all

Hospital Affiliations